4ABio
 |
||
4A is een biotechbedrijf dat zich richt op activiteiten met betrekking tot antilichamen. 4A Biotech heeft een reeks ELISA-kits en honderden monoklonale antilichamen tegen kanker (met name leukemie) ontwikkeld, evenals producten voor immunologisch onderzoek. | ||
SARS-CoV-2 - Secondary antibodies for research and development
The current COVID-19 pandemic has sickened more than 520,000 people worldwide and continues to increase daily. There is an urgent need to increase current diagnostic capacity. Compared to the commonly used PCR test, the diagnostic method based on the serological test is much easier and faster to perform. To support the development of immunodiagnostic methods, we offer a comprehensive collection of antibodies and antigens for SARS-CoV-2.
We offer a full range of antibodies to human IgG and IgM for research and development of kits for the detection of anti-SARS-CoV-2 antibodies in patient samples.
Rapid tests for the screening of COVID-19 affected patients, based on the principle of immunochromatography, use anti-human IgG and IgM antibodies to detect anti-SARS-CoV-2 antibodies produced by patients in serum, plasma or whole blood samples.
Resultaat van uw zoeken : 2 product gevonden
Verfijn uw zoekopdracht :
RUOCE / IVD
- FITC 1
- PE 1
- goat 1
- human 1
- Secondary antibody
- goat 1
- rabbit 1
- FC 2
Referentie
Beschrijving
Cond.
Price Bef. VAT
‹
›